Enzo Biochem, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Supplemental disclosure for statement of cash flows

Supplemental disclosure for statement of cash flows	6 Months Ended
Jan. 31, 2017
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	Note 3 - Supplemental disclosure for statement of cash flows For the six months ended January 31, 2017 and 2016, income taxes paid by the Company were $996 and $53, respectively. For the six months ended January 31, 2017 and 2016, interest paid by the Company was $77. For the six months ended January 31, 2017 and 2016, the Company financed $69 and $76 respectively, in machinery and transportation equipment under installment loans. During the six months ended January 31, 2017, the Company did not enter into any capital lease agreements. During the six months ended January 31, 2016, there was a total of $1,141 in capital lease agreements.

Supplemental disclosure for statement of cash flows

6 Months Ended

Jan. 31, 2017

Supplemental Cash Flow Elements [Abstract]

Cash Flow, Supplemental Disclosures [Text Block]

Note 3 - Supplemental disclosure for statement of cash flows

For the six months ended January 31, 2017 and 2016, income taxes paid by the Company were $996 and $53, respectively.

For the six months ended January 31, 2017 and 2016, interest paid by the Company was $77.

For the six months ended January 31, 2017 and 2016, the Company financed $69 and $76 respectively, in machinery and transportation equipment under installment loans.

During the six months ended January 31, 2017, the Company did not enter into any capital lease agreements. During the six months ended January 31, 2016, there was a total of $1,141 in capital lease agreements.